The 7investing Podcast
En podkast av 7investing
477 Episoder
-
7investing Explains: How are Medical Devices and Genetic Tests Regulated?
Publisert: 25.1.2022 -
Welcome Luke Hallard to 7investing!
Publisert: 20.1.2022 -
Why Have Growth Stocks Plummeted? An Interview with Tobias Carlisle
Publisert: 18.1.2022 -
5 Big Reveals from the 2022 JP Morgan Healthcare Conference
Publisert: 13.1.2022 -
Improving Your Decision-Making Process with Krzysztof Piekarski
Publisert: 11.1.2022 -
Buy Castlight Health: A 7investing Deep Dive
Publisert: 6.1.2022 -
Navigating Market Volatility with ChitChatMoney's Ryan Henderson and Brett Schafer
Publisert: 4.1.2022 -
Buy Dicerna Pharmaceuticals: A 7investing Deep Dive
Publisert: 29.12.2021 -
Investing in Emerging Markets with Perth Tolle
Publisert: 16.12.2021 -
The Power of Investing Young with Maya and Soren Peterson
Publisert: 9.12.2021 -
What's Next for Synthetic Biology?
Publisert: 30.11.2021 -
Digital Advertising's New Future with PubMatic CEO Rajeev Goel
Publisert: 18.11.2021 -
Tesla and Technical Analysis with O'Neil Advisors' Irusha Peiris
Publisert: 11.11.2021 -
A CEO's Perspective of Investing in Biotechs with Al Altomari, CEO of Agile Therapeutics
Publisert: 9.11.2021 -
Is Peloton a Good Investment?
Publisert: 9.11.2021 -
Zillow Drops iBuying; What’s a Metaverse?
Publisert: 5.11.2021 -
Investing in Environmental, Social, and Governance with Corbin Advisors SVP Robert McConnaughey
Publisert: 4.11.2021 -
Apple Results, Amazon, Microsoft, Google, and the Cloud
Publisert: 3.11.2021 -
What Does the Future of Sports Betting Look Like in the U.S.?
Publisert: 27.10.2021 -
Is it too Late to Buy Tesla?
Publisert: 25.10.2021
Welcome to 7investing.com. Our mission is to empower you to invest in your future. This podcast brings our market-based experts together to discuss our investing process and important news. Once a month, we will also feature interviews with some of the best minds in business and investing. Check out 7investing.com to find more of our free content and premium monthly stock recommendations.